PE20050395A1 - PROCEDIMIENTOS DE PREPARACION DE DERIVADOS DE ACIDO PIRROLIDIN-1,2-DICARBOXILICO-1-(FENIL(-AMIDA))-2-(FENIL(-AMIDA)) Y ACIDO-1-(FENILCARBAMOIL)-PIRROLIDIN-2-CARBOXILICO COMO INHIBIDORES DEL FACTOR Xa - Google Patents
PROCEDIMIENTOS DE PREPARACION DE DERIVADOS DE ACIDO PIRROLIDIN-1,2-DICARBOXILICO-1-(FENIL(-AMIDA))-2-(FENIL(-AMIDA)) Y ACIDO-1-(FENILCARBAMOIL)-PIRROLIDIN-2-CARBOXILICO COMO INHIBIDORES DEL FACTOR XaInfo
- Publication number
- PE20050395A1 PE20050395A1 PE2004000349A PE2004000349A PE20050395A1 PE 20050395 A1 PE20050395 A1 PE 20050395A1 PE 2004000349 A PE2004000349 A PE 2004000349A PE 2004000349 A PE2004000349 A PE 2004000349A PE 20050395 A1 PE20050395 A1 PE 20050395A1
- Authority
- PE
- Peru
- Prior art keywords
- pyrrolidin
- phenyl
- amide
- acid
- oxo
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 7
- 108010074860 Factor Xa Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 2
- -1 PHENYLCARBAMOYL Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 abstract 3
- 230000001131 transforming effect Effects 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009424 thromboembolic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE COMPUESTOS DERIVADOS DE PIRROLIDINA DE FORMULA (I), EN DONDE R ES HAL O CºCH; R1 ES H, =O, HAL, A, OH, A-COO-, ENTRE OTROS; R2 ES H, HAL O A; R3 ES 2-OXO-PIPERIDIN-1-ILO, 2-OXO-PIRROLIDIN-1-ILO, 2-OXO-1H-PIRIDIN-1-ILO, ENTRE OTROS; A ES ALQUILO LINEAL, RAMIFICADO O CICLICO(C1-C10), QUE COMPRENDE EN: a) TRANSFORMAR UN ACIDO R1-PIRROLIDIN-2-CARBOXILICO (CIS R1-D-PROLINA) CON UN 4-R-FENILISOCIANATO PARA DAR UN ACIDO -1-(4-R-FENILCARBAMIL-R1-PIRROLIDIN-2-CARBOXILICO b) TRANSFORMAR EL COMPUESTO OBTENIDO ANTERIORMENTE CON UN AMINOFENILR3R2, PARA DAR EL COMPUESTO DE FORMULA I, Y c) CONVERTIR EL MISMO, EN SUS DERIVADOS Y/O SOLVATOS DE USO FARMACEUTICO TRANSFORMANDO UNA BASE O UN ACIDO EN SUS SALES. SON COMPUESTOS PREFERIDOS: ACIDO (2R,4R)-4-HIDROXI-PIRROLIDIN-1,2-DICARBOXILICO-1-[(4-CLORO-FENIL)-AMIDO]-2-{[4-(3-OXO-MORFOLIN-4-IL)-FENIL]-AMIDA}, ACIDO (2R)-PIRROLIDIN-1,2-DICARBOXILICO-1-[(4-CLORO-FENIL)-AMIDO]-2-{[3-TRIFLUOROMETIL-4-(3-OXO-MORFOLIN-4-IL)-FENIL]-AMIDA}, ACIDO (2R,4S)-4-METOXI-PIRROLIDIN-1,2-DICARBOXILICO-1-[(4-CLORO-FENIL)-AMIDO]-2-{[4-(3-OXO-MORFOLIN-4-IL)-FENIL]-AMIDA}, ENTRE OTROS. ESTOS COMPUESTOS SON INHIBIDORES DEL FACTOR Xa Y SON UTILES PARA TRATAR Y/O PREVENIR ENFERMEDADES TROMBOEMBOLICAS COMO TROMBOSIS, INFARTO DEL MIOCARDIO, ARTERIOSCLEROSIS, INFLAMACIONES, APOPLEJIA, ANGINA DE PECHO, RESTONOSIS POSTERIORES A ANGIOPLASTIA Y CLAUDICACION INTERMITENTE
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10315377A DE10315377A1 (de) | 2003-04-03 | 2003-04-03 | Carbonylverbindungen |
| DE10327428A DE10327428A1 (de) | 2003-06-18 | 2003-06-18 | Ethinylprolinderivate |
| DE2003129295 DE10329295A1 (de) | 2003-06-30 | 2003-06-30 | Carbonylverbindungen |
| DE10329457A DE10329457A1 (de) | 2003-04-03 | 2003-07-01 | Ethinylprolinderivate |
| DE2003134174 DE10334174A1 (de) | 2003-07-26 | 2003-07-26 | Pyrrolidinderivate und Verfahren zur Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050395A1 true PE20050395A1 (es) | 2005-06-04 |
Family
ID=33136213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004000349A PE20050395A1 (es) | 2003-04-03 | 2004-04-02 | PROCEDIMIENTOS DE PREPARACION DE DERIVADOS DE ACIDO PIRROLIDIN-1,2-DICARBOXILICO-1-(FENIL(-AMIDA))-2-(FENIL(-AMIDA)) Y ACIDO-1-(FENILCARBAMOIL)-PIRROLIDIN-2-CARBOXILICO COMO INHIBIDORES DEL FACTOR Xa |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7504500B2 (es) |
| EP (1) | EP1608646B1 (es) |
| JP (1) | JP4634369B2 (es) |
| KR (1) | KR20050118709A (es) |
| AR (1) | AR043831A1 (es) |
| AT (1) | ATE366732T1 (es) |
| AU (1) | AU2004226280B2 (es) |
| BR (1) | BRPI0408888A (es) |
| CA (1) | CA2520893C (es) |
| DE (2) | DE10329457A1 (es) |
| ES (1) | ES2287708T3 (es) |
| MX (1) | MXPA05010433A (es) |
| PE (1) | PE20050395A1 (es) |
| PL (1) | PL377138A1 (es) |
| TW (1) | TW200500339A (es) |
| WO (1) | WO2004087695A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050119266A1 (en) * | 2003-10-01 | 2005-06-02 | Yan Shi | Pyrrolidine and piperidine derivatives as factor Xa inhibitors |
| DE102004004731A1 (de) * | 2004-01-30 | 2005-08-18 | Merck Patent Gmbh | Harnstoffderivate |
| DE102004045796A1 (de) * | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
| DE102004047254A1 (de) * | 2004-09-29 | 2006-04-13 | Merck Patent Gmbh | Carbonylverbindungen |
| DE102004050283A1 (de) * | 2004-10-15 | 2006-04-27 | Lanxess Deutschland Gmbh | 4-Aminophenyl-morpholinon-Derivate und deren Herstellung |
| US7301817B2 (en) * | 2005-10-27 | 2007-11-27 | Sandisk Corporation | Method for programming of multi-state non-volatile memory using smart verify |
| AU2006314637A1 (en) * | 2005-11-16 | 2007-05-24 | F. Hoffmann-La Roche Ag | Novel pyrrolidine derivatives as inhibitors of coagulation factor Xa |
| EP1818330A1 (de) * | 2006-02-14 | 2007-08-15 | Boehringer Ingelheim Pharma GmbH & Co.KG | Substituierte Prolinamide, deren Herstellung und deren Verwendung als Arzneimittel |
| EA200802210A1 (ru) | 2006-05-16 | 2009-06-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств |
| US8673920B2 (en) | 2009-05-06 | 2014-03-18 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2632465B1 (en) | 2010-10-27 | 2015-12-30 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9056859B2 (en) | 2010-10-29 | 2015-06-16 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2744499B1 (en) | 2011-08-19 | 2016-09-28 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9527830B2 (en) | 2011-09-16 | 2016-12-27 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2013062892A1 (en) | 2011-10-25 | 2013-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2013062900A1 (en) | 2011-10-25 | 2013-05-02 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2773351B1 (en) | 2011-10-31 | 2017-08-23 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2773199B1 (en) | 2011-10-31 | 2019-04-10 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2773206B1 (en) | 2011-10-31 | 2018-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2790511B1 (en) | 2011-12-16 | 2016-09-14 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| AR092031A1 (es) | 2012-07-26 | 2015-03-18 | Merck Sharp & Dohme | Inhibidores del canal de potasio medular externo renal |
| US9777002B2 (en) | 2012-11-29 | 2017-10-03 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9573961B2 (en) | 2012-12-19 | 2017-02-21 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| EP2956142B1 (en) | 2013-02-18 | 2017-09-20 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9765074B2 (en) | 2013-03-15 | 2017-09-19 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| US9751881B2 (en) | 2013-07-31 | 2017-09-05 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
| WO2015065866A1 (en) | 2013-10-31 | 2015-05-07 | Merck Sharp & Dohme Corp. | Inhibitors of the renal outer medullary potassium channel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5822111B2 (ja) * | 1977-10-29 | 1983-05-06 | 協和醗酵工業株式会社 | 柑橘類果実の改質剤 |
| JPS63232846A (ja) * | 1987-03-20 | 1988-09-28 | Haruo Ogura | 新規な固定相担体 |
| AU4966497A (en) * | 1996-11-18 | 1998-06-10 | Yamanouchi Pharmaceutical Co., Ltd. | Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same |
| US7030141B2 (en) * | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
-
2003
- 2003-07-01 DE DE10329457A patent/DE10329457A1/de not_active Withdrawn
-
2004
- 2004-03-09 DE DE502004004294T patent/DE502004004294D1/de not_active Expired - Lifetime
- 2004-03-09 ES ES04718646T patent/ES2287708T3/es not_active Expired - Lifetime
- 2004-03-09 AU AU2004226280A patent/AU2004226280B2/en not_active Ceased
- 2004-03-09 KR KR1020057018640A patent/KR20050118709A/ko not_active Withdrawn
- 2004-03-09 CA CA2520893A patent/CA2520893C/en not_active Expired - Fee Related
- 2004-03-09 AT AT04718646T patent/ATE366732T1/de not_active IP Right Cessation
- 2004-03-09 US US10/551,670 patent/US7504500B2/en not_active Expired - Fee Related
- 2004-03-09 WO PCT/EP2004/002405 patent/WO2004087695A1/de not_active Ceased
- 2004-03-09 MX MXPA05010433A patent/MXPA05010433A/es not_active Application Discontinuation
- 2004-03-09 PL PL377138A patent/PL377138A1/pl unknown
- 2004-03-09 JP JP2006504602A patent/JP4634369B2/ja not_active Expired - Fee Related
- 2004-03-09 EP EP04718646A patent/EP1608646B1/de not_active Expired - Lifetime
- 2004-03-09 BR BRPI0408888-3A patent/BRPI0408888A/pt not_active Application Discontinuation
- 2004-03-31 TW TW093108904A patent/TW200500339A/zh unknown
- 2004-04-02 PE PE2004000349A patent/PE20050395A1/es not_active Application Discontinuation
- 2004-04-02 AR ARP040101113A patent/AR043831A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE366732T1 (de) | 2007-08-15 |
| US20060211692A1 (en) | 2006-09-21 |
| MXPA05010433A (es) | 2005-11-04 |
| US7504500B2 (en) | 2009-03-17 |
| CA2520893C (en) | 2012-07-10 |
| AU2004226280B2 (en) | 2010-06-17 |
| PL377138A1 (pl) | 2006-01-23 |
| TW200500339A (en) | 2005-01-01 |
| ES2287708T3 (es) | 2007-12-16 |
| JP4634369B2 (ja) | 2011-02-16 |
| DE10329457A1 (de) | 2005-01-20 |
| AR043831A1 (es) | 2005-08-17 |
| AU2004226280A1 (en) | 2004-10-14 |
| EP1608646A1 (de) | 2005-12-28 |
| DE502004004294D1 (de) | 2007-08-23 |
| KR20050118709A (ko) | 2005-12-19 |
| JP2006522037A (ja) | 2006-09-28 |
| WO2004087695A1 (de) | 2004-10-14 |
| BRPI0408888A (pt) | 2006-04-11 |
| CA2520893A1 (en) | 2004-10-14 |
| EP1608646B1 (de) | 2007-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050395A1 (es) | PROCEDIMIENTOS DE PREPARACION DE DERIVADOS DE ACIDO PIRROLIDIN-1,2-DICARBOXILICO-1-(FENIL(-AMIDA))-2-(FENIL(-AMIDA)) Y ACIDO-1-(FENILCARBAMOIL)-PIRROLIDIN-2-CARBOXILICO COMO INHIBIDORES DEL FACTOR Xa | |
| PE20070593A1 (es) | Compuestos pirrolopirimidina como inhibidores de syk | |
| TW200736221A (en) | Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor | |
| EA201001556A1 (ru) | Соединения, включающие противовоспалительный фармакофор, и способы их применения | |
| EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| CU23515A3 (es) | Nuevo proceso para la síntesis y nueva forma cristalina de agomelatina y composiciones farmacéuticas que la contienen | |
| EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
| EA200702670A1 (ru) | Препарат тиенопиридинового ингибитора агрегации тромбоцитов | |
| EA200401157A1 (ru) | N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv | |
| EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| IS2416B (is) | Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar | |
| PE20091400A1 (es) | Derivados de n-(2-amino-fenil)-amida como inhibidores de hdac | |
| UY31986A (es) | Derivados n- sustituídos de la 2-metil-propionamida;{1-[5-sustiuido-4-sustituido-tiazol-2-il-carbamoil]-1-metil-etil} amidas de ácidos carboxílicos sustituidos, derivados farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
| PE20091673A1 (es) | Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilizacion | |
| EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
| EA200970207A1 (ru) | Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов | |
| EA200601459A1 (ru) | НОВЫЕ АМИДЫ КАРБОНОВЫХ КИСЛОТ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa | |
| ATE457302T1 (de) | Aromatische etherderivate als thrombin-hemmer | |
| EA200800791A1 (ru) | Сульфонилпирролгидрохлориды, как ингибиторы гистондезацетилазы | |
| PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
| RU2008136763A (ru) | Гетероциклические противовирусные соединения | |
| PE20070619A1 (es) | TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA | |
| EA202191995A1 (ru) | Циклические молекулы в качестве ингибитора тирозинкиназы брутона |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |